AUERBACH ALAN H
SEC insider (Form 3/4/5 filer). CIK 0001358285. President and CEO at PUMA BIOTECHNOLOGY, INC. (PBYI). 8 reported Form 4/5 transactions since Sep 2024; latest on Jul 6, 2026. Located in LOS ANGELES, CA.
Companies AUERBACH ALAN H has filed insider reports for
- PUMA BIOTECHNOLOGY, INC. (PBYI): Director, Officer, 10% Owner, President and CEO
AUERBACH ALAN H
CIK: 0001358285
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PUMA BIOTECHNOLOGY, INC.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jul 6, 2026PBYI
PUMA BIOTECHNOLOGY, INC.
SaleDirect44.1K shares at avg. $8.26$364K - Feb 18, 2026PBYI
PUMA BIOTECHNOLOGY, INC.
AwardDirect159.8K shares- - Jan 7, 2026PBYI
PUMA BIOTECHNOLOGY, INC.
SaleDirect18K shares at avg. $5.88$106K - Jan 6, 2026PBYI
PUMA BIOTECHNOLOGY, INC.
SaleDirect16.9K shares at avg. $5.84$99K - Jul 9, 2025PBYI
PUMA BIOTECHNOLOGY, INC.
SaleDirect21.6K shares at avg. $3.54$76K - Jul 8, 2025PBYI
PUMA BIOTECHNOLOGY, INC.
SaleDirect25.6K shares at avg. $3.53$90K - Feb 7, 2025PBYI
PUMA BIOTECHNOLOGY, INC.
AwardDirect198.4K shares- - Jan 2, 2025PBYI
PUMA BIOTECHNOLOGY, INC.
SaleDirect33.8K shares at avg. $3.15$107K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 6, 2026 | PBYI PUMA BIOTECHNOLOGY, INC. | Sale | 44,058 | $8.26 | $364,051 | Direct |
| Feb 18, 2026 | PBYI PUMA BIOTECHNOLOGY, INC. | Award | 159,778 | - | $0 | Direct |
| Jan 7, 2026 | PBYI PUMA BIOTECHNOLOGY, INC. | Sale | 18,012 | $5.88 | $105,893 | Direct |
| Jan 6, 2026 | PBYI PUMA BIOTECHNOLOGY, INC. | Sale | 16,938 | $5.84 | $98,986 | Direct |
| Jul 9, 2025 | PBYI PUMA BIOTECHNOLOGY, INC. | Sale | 21,580 | $3.54 | $76,285 | Direct |
| Jul 8, 2025 | PBYI PUMA BIOTECHNOLOGY, INC. | Sale | 25,592 | $3.53 | $90,417 | Direct |
| Feb 7, 2025 | PBYI PUMA BIOTECHNOLOGY, INC. | Award | 198,399 | - | - | Direct |
| Jan 2, 2025 | PBYI PUMA BIOTECHNOLOGY, INC. | Sale | 33,841 | $3.15 | $106,657 | Direct |
1-8 of 8 transactions